Literature DB >> 7932921

Schistosomiasis vaccines: Farewell to the God of Plague?

M G Taylor1.   

Abstract

Control and even eradication of schistosomiasis have been achieved in some countries using integrated measures but this disease remains endemic in 74 countries with 600 million at risk of whom 200 million are currently infected. The application of control measures, particularly population-based chemotherapy, has in many countries greatly reduced the incidence of serious disease manifestations, but vaccines are urgently needed to supplement existing control measures. Great advances are being made in vaccine development and the first clinical trials are expected to begin shortly.

Entities:  

Keywords:  Diseases; Epidemiology; Health; Historical Survey; Parasite Control; Parasitic Diseases; Public Health; Research Activities; Research Methodology; Treatment; Vaccines

Mesh:

Substances:

Year:  1994        PMID: 7932921

Source DB:  PubMed          Journal:  J Trop Med Hyg        ISSN: 0022-5304


  2 in total

1.  Interleukin-12 as an adjuvant for an antischistosome vaccine consisting of adult worm antigens: protection of rats from cercarial challenge.

Authors:  R D Bungiro; M Goldberg; P K Suri; P M Knopf
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Local immune responses of the Chinese water buffalo, Bubalus bubalis, against Schistosoma japonicum larvae: crucial insights for vaccine design.

Authors:  Hamish E G McWilliam; David Piedrafita; Yuesheng Li; Mao Zheng; Yongkang He; Xinling Yu; Donald P McManus; Els N T Meeusen
Journal:  PLoS Negl Trop Dis       Date:  2013-09-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.